Home›Stock Screener›Rubicon Research›Quarterly Results

Rubicon Research Quarterly Results

Latest Quarter Net Profit
₹90 Cr
QSept 2026
Quarterly Results

Rubicon Research quarterly results. In Sept 2026, Rubicon Research (RUBICON) reported revenue ₹579 Cr and net profit ₹90 Cr — revenue +40.2% YoY. View RUBICON yearly price range for the annual high/low range and current price position.

RUBICON Quarterly Results — Revenue, Profit & EPS Highlights

Rubicon Research latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore RUBICON price trends to track price trends across different timeframes.

  • Revenue of ₹579 Cr in Sept 2026 (+12.0% vs Mar 2026, +40.2% vs Sept 2025)
  • Net Profit of ₹90 Cr in Sept 2026 (+16.9% vs Mar 2026, +66.7% vs Sept 2025)
  • EBITDA of ₹146 Cr in Sept 2026 (+20.7% vs Mar 2026)
  • Operating Margin of 25.0% in Sept 2026 (+2.0pp vs Mar 2026)
  • Earnings Per Share of ₹5.47 in Sept 2026 (+16.9% vs Mar 2026)

Rubicon Research Quarterly Results — Revenue, EBITDA, Net Profit & EPS

RUBICON quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 579 517 540 413 358 12.0% 40.2%
Net Profit (₹ Cr) 90 77 85 54 36 - -
EBITDA (₹ Cr) 146 121 135 95 73 - -
EPS (₹) 5.47 4.68 5.13 3.49 2.37 - -
Operating Margin (%) 25.0% 23.0% 24.0% 23.0% 20.0% - -

RUBICON Share Price Trend — 1-Year Movement Across Quarterly Results

Rubicon Research 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Rubicon Research share price screener.

Profitability Ratios

Profit Margin 15.5%
EBITDA Margin 25.2%
Operating Margin 25.0%
ROE (Annual) 27.9%

Balance Sheet Highlights

Total Assets ₹2,327 Cr
Total Equity ₹1,289 Cr
Current Assets ₹ Cr
Current Liabilities ₹202 Cr

Cash Flow Analysis

Operating Cash Flow ₹205 Cr
Investing Cash Flow ₹-407 Cr
Financing Cash Flow ₹283 Cr
Net Cash Flow ₹81 Cr

Current Market Data

Current Price ₹1722.30
Exchange NSE
Last Updated Nov 19, 2026

RUBICON vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Rubicon Research latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores